Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,478 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis.
Schettini F, Nucera S, Pascual T, Martínez-Sáez O, Sánchez-Bayona R, Conte B, Buono G, Lambertini M, Punie K, Cejalvo JM, Arpino G, Vigneri P, Generali D, Ciruelos E, Cortés J, Gennari A, Muñoz M, Vidal Losada MJ, Tolaney SM, Prat A, Villacampa G. Schettini F, et al. Among authors: munoz m. Cancer Treat Rev. 2024 Dec 19;132:102865. doi: 10.1016/j.ctrv.2024.102865. Online ahead of print. Cancer Treat Rev. 2024. PMID: 39709655 Free article. Review.
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial.
Kalinsky K, Bianchini G, Hamilton E, Graff SL, Park KH, Jeselsohn R, Martin M, Layman RM, Hurvitz SA, Sammons S, Kaufman PA, Muñoz M, Lai JI, Knoderer H, Sandoval C, Chawla AR, Nguyen B, Zhou Y, Ravenberg E, Litchfield LM, Smyth L, Wander SA. Kalinsky K, et al. Among authors: munoz m. J Clin Oncol. 2024 Dec 18:JCO2402086. doi: 10.1200/JCO-24-02086. Online ahead of print. J Clin Oncol. 2024. PMID: 39693591
Systematic Coronary Risk Evaluation 2 for Older Persons (SCORE2-OP): 10 years risk validation, clinical utility and potential improvement.
Belahnech Y, Ródenas-Alesina E, Muñoz MÁ, Verdu-Rotellar JM, Sao-Avilés A, Urio-Garmendia G, Osorio D, Salas K, Pantoja E, Ribera A, Ferreira-González I. Belahnech Y, et al. Among authors: munoz ma. Eur J Prev Cardiol. 2024 Dec 5:zwae383. doi: 10.1093/eurjpc/zwae383. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 39657030
3,478 results